Furthermore, previous studies have demonstrated the anti-inflammatory effects of ghrelin in multiple pathological conditions, including endotoxic shock [20], sepsis [21], and experimental colitis [22,23,24,25]; however, the cellular and molecular mechanisms mediating the therapeutic effects of ghrelin are less clear. The gene discussed is GHRL; the disease is colitis.